Cargando…
The benefits and side effects of gadolinium-based contrast agents in multiple sclerosis patients
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Associação Médica Brasileira
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574993/ https://www.ncbi.nlm.nih.gov/pubmed/36134822 http://dx.doi.org/10.1590/1806-9282.20220643 |
_version_ | 1784811225241092096 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9574993 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Associação Médica Brasileira |
record_format | MEDLINE/PubMed |
spelling | pubmed-95749932022-10-19 The benefits and side effects of gadolinium-based contrast agents in multiple sclerosis patients Rev Assoc Med Bras (1992) Editorial Associação Médica Brasileira 2022-09-19 /pmc/articles/PMC9574993/ /pubmed/36134822 http://dx.doi.org/10.1590/1806-9282.20220643 Text en https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Editorial The benefits and side effects of gadolinium-based contrast agents in multiple sclerosis patients |
title | The benefits and side effects of gadolinium-based contrast agents in multiple sclerosis patients |
title_full | The benefits and side effects of gadolinium-based contrast agents in multiple sclerosis patients |
title_fullStr | The benefits and side effects of gadolinium-based contrast agents in multiple sclerosis patients |
title_full_unstemmed | The benefits and side effects of gadolinium-based contrast agents in multiple sclerosis patients |
title_short | The benefits and side effects of gadolinium-based contrast agents in multiple sclerosis patients |
title_sort | benefits and side effects of gadolinium-based contrast agents in multiple sclerosis patients |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574993/ https://www.ncbi.nlm.nih.gov/pubmed/36134822 http://dx.doi.org/10.1590/1806-9282.20220643 |